Document is current
Any future updates will be listed below
-
Authors
Steen, Sanna
Karlsson, Emelie
Björnheden, Ida
Rask, Gunilla
Thurfjell, Viktoria
Nobin, Hampus
Kolodziej, Blanka
Bodén, Anna
Bauer, Annette
Einefors, Rickard
Nilsson, Per
Zerdes, Ioannis
Papakonstantinou, Andri
Foukakis, Theodoros
Fredriksson, Irma
Rantalainen, Mattias
Colón-Cervantes, Eugenia
Kovács, Anikó
Acs, Balazs
Hartman, Johan
-
Funding
Funding for this research was provided by:
Karolinska Institute
- License Information
-
More Information
Article History
Received: 7 September 2025
Accepted: 17 November 2025
First Online: 29 November 2025
Declarations
:
: The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Swedish Ethical Review Authority and the Ethical Review Board in Stockholm. No specific informed consent for participation was obtained from the patients for this observational non-interventional study, but general consent had already been provided. All data used were de-identified prior to analysis and publication.
: Not applicable.
: JH has obtained speaker’s honoraria or advisory board remunerations from Roche, Novartis, Pfizer, EliLilly, MSD, Gilead, Sakura and has received institutional research support from Roche, AstraZeneca, MSD, and Novartis. JH and MR are co-founders and shareholders of Stratipath AB. BA reports honoraria from Pfizer. ABo has obtained per diem advisory board reimbursement from Sectra. I.F. has received institutional funding from MSD as part of a Master Collaboration Agreement between MSD and Karolinska Institutet. AK received honoraria from Roche, Pfizer and Astra Zeneca.All other authors report no conflict of interest.
